DSM invests in Bioprocess Control AB to optimize biogas processes
DSM Venturing, the corporate venturing unit of Royal DSM N.V., announced that it has made an equity investment in Bioprocess Control AB. In addition to the investment, a strategic cooperation agreement has been signed which will enable DSM and Bioprocess Control AB to leverage their complementary activities in the area of biogas. Financial details will not be disclosed.
Bioprocess Control AB, based in Lund (Sweden), is an innovation-driven company with a strong portfolio of products that significantly improve both the design and operation of biogas plants. Its prize-winning product, Biogas OptimizerTM, is a process diagnosis, decision support and optimization application and an advanced advisory service that can allow biogas producers to reach the upper limits of their production capacity and stabilize the biogas process, providing for both increased revenues and process savings at their customers' sites.
Rob van Leen, Chief Innovation Officer of DSM, said: "We look forward to working with Bioprocess Control to optimize the production efficiency of biogas processes. Our combined technologies will considerably increase the performance of biogas plants, resulting in additional economic value for the biogas producers. Our cooperation is an important next step in this emerging but fast expanding market."
Other news from the department business & finance
